I agree that this site is using cookies. You can find further informations here.
X
Armuzzi, A
1040  results:
?
1

P931 Burden of disease among Ulcerative Colitis patients wi..:

Armuzzi, A ; Danese, S ; Barreiro-de Acosta, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1694-i1696 , 2024
Link: https://doi.org/10.1093/..
 
?
2

T.05.5: EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH ULCE..:

Teani, I. ; Bevilacqua, N. ; Gabbiadini, R....
Digestive and Liver Disease.  56 (2024)  - p. S244-S245 , 2024
Link: https://doi.org/10.1016/..
 
?
3

P881 Real-life vs trial access to biologic therapy differen..:

DI VINCENZO, F ; Maresca, R ; Mora, V...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1624-i1624 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P1062 Effectiveness and safety outcomes beyond five years o..:

Privitera, G ; Pugliese, D ; Armuzzi, A
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1909-i1909 , 2024
Link: https://doi.org/10.1093/..
 
?
5

OC.07.7: SUSTAINED IMPROVEMENT IN INFLAMMATORY BOWEL DISEAS..:

Sands, B.E. ; Feagan, B.G. ; Armuzzi, A....
Digestive and Liver Disease.  56 (2024)  - p. S166 , 2024
Link: https://doi.org/10.1016/..
 
?
6

P109 Organic Cation Transporter (OCTN)-1 variants shape inn..:

Capobianco, I ; Puca, P ; Masi, L...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i392-i393 , 2024
Link: https://doi.org/10.1093/..
 
?
7

P862 Effects of induction and maintenance therapy with risa..:

Panés, J ; Loftus Jr., E V ; Armuzzi, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1596-i1597 , 2024
Link: https://doi.org/10.1093/..
 
?
8

P1019 "Totality-of-the-evidence" of proposed ustekinumab bi..:

Armuzzi, A ; Girolomoni, G ; Feldman, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1841-i1843 , 2024
Link: https://doi.org/10.1093/..
 
?
9

P079 Low-intensity Pulsed Ultrasound reflects the status of..:

Pineda Chavez, S E ; Carriles Linares, A ; Rizzo, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i352-i352 , 2024
Link: https://doi.org/10.1093/..
 
?
10

P535 Effectiveness of upadacitinib in patients with Ulcerat..:

Teani, I ; Bevilacqua, N ; Gabbiadini, R...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1052-i1053 , 2024
Link: https://doi.org/10.1093/..
 
?
11

A 1-year follow-up study on checkpoint inhibitor-induced co..:

Lenti, M.V. ; Ribaldone, D.G. ; Borrelli de Andreis, F....
ESMO Open.  9 (2024)  7 - p. 103632 , 2024
Link: https://doi.org/10.1016/..
 
?
12

OP06 Risankizumab Maintenance Therapy in Patients With Mode..:

Louis, E ; Panaccione, R ; Parkes, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i10-i12 , 2024
Link: https://doi.org/10.1093/..
 
?
13

P789 Impact of risk factors for Janus kinase inhibitor use ..:

Siegmund, B ; Kuehbacher, T ; Armuzzi, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1471-i1473 , 2024
Link: https://doi.org/10.1093/..
 
?
14

BOC.03.1: EFFECTIVENESS AND SAFETY OUTCOMES BEYOND FIVE YEA..:

Privitera, G. ; Pugliese, D. ; Armuzzi, A.
Digestive and Liver Disease.  56 (2024)  - p. S114 , 2024
Link: https://doi.org/10.1016/..
 
?
15

P715 Multiparametric assessment of IBD and SpA-IBD patients..:

Privitera, G ; Parisio, L ; Perniola, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1346-i1346 , 2024
Link: https://doi.org/10.1093/..
 
1-15